Metropolitan Life Insurance Company (MetLife)’s Blueprint Medicines BPMC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2024
Q2
Sell
-3,194
Closed -$303K 319
2024
Q1
$303K Sell
3,194
-310
-9% -$29.4K 0.01% 582
2023
Q4
$323K Hold
3,504
0.02% 557
2023
Q3
$176K Buy
3,504
+189
+6% +$9.49K 0.01% 740
2023
Q2
$210K Hold
3,315
0.01% 662
2023
Q1
$149K Sell
3,315
-362
-10% -$16.3K 0.01% 789
2022
Q4
$161K Hold
3,677
0.01% 809
2022
Q3
$242K Hold
3,677
0.01% 607
2022
Q2
$186K Hold
3,677
0.01% 725
2022
Q1
$235K Sell
3,677
-11,215
-75% -$716K 0.01% 740
2021
Q4
$1.6M Sell
14,892
-434
-3% -$46.5K 0.02% 659
2021
Q3
$1.58M Sell
15,326
-726
-5% -$74.6K 0.02% 642
2021
Q2
$1.41M Buy
16,052
+1,003
+7% +$88.2K 0.02% 748
2021
Q1
$1.46M Sell
15,049
-543
-3% -$52.8K 0.02% 710
2020
Q4
$1.75M Sell
15,592
-136
-0.9% -$15.3K 0.03% 543
2020
Q3
$1.46M Sell
15,728
-761
-5% -$70.5K 0.02% 548
2020
Q2
$1.29M Buy
16,489
+236
+1% +$18.4K 0.02% 598
2020
Q1
$950K Buy
16,253
+758
+5% +$44.3K 0.02% 701
2019
Q4
$1.24M Sell
15,495
-458
-3% -$36.7K 0.02% 772
2019
Q3
$1.17M Buy
15,953
+1,078
+7% +$79.2K 0.02% 775
2019
Q2
$1.4M Buy
14,875
+1,578
+12% +$149K 0.02% 695
2019
Q1
$1.06M Sell
13,297
-179
-1% -$14.3K 0.02% 845
2018
Q4
$726K Hold
13,476
0.01% 980
2018
Q3
$1.05M Hold
13,476
0.02% 904
2018
Q2
$855K Hold
13,476
0.01% 1000
2018
Q1
$1.24M Buy
13,476
+804
+6% +$73.7K 0.02% 805
2017
Q4
$956K Sell
12,672
-13,607
-52% -$1.03M 0.01% 918
2017
Q3
$1.83M Sell
26,279
-263
-1% -$18.3K 0.01% 965
2017
Q2
$1.35M Buy
26,542
+9,387
+55% +$476K 0.01% 1096
2017
Q1
$686K Buy
17,155
+1,589
+10% +$63.5K ﹤0.01% 1441
2016
Q4
$437K Hold
15,566
﹤0.01% 1829
2016
Q3
$462K Hold
15,566
﹤0.01% 1757
2016
Q2
$315K Buy
15,566
+7,281
+88% +$147K ﹤0.01% 2001
2016
Q1
$150K Sell
8,285
-598
-7% -$10.8K ﹤0.01% 2343
2015
Q4
$234K Hold
8,883
﹤0.01% 2142
2015
Q3
$190K Sell
8,883
-71
-0.8% -$1.52K ﹤0.01% 2315
2015
Q2
$237K Buy
+8,954
New +$237K ﹤0.01% 2284